Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:4-Hydroxyphenyl-2-propionic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004189 AN007234 Discovery and Validation of Metabolic Biomarkers for 'Liver Qi Stagnation' and 'Liver-Gallbladder Damp-Heat' Syndromes in Cholelithiasis: Urine untargeted Urine Human Gallstones First Affiliated Hospital of Dalian Medical University LC-MS
ST004035 AN006673 Serum Metabolites at Defined Stages of Liver Disease Liver Mouse Liver disease University of Texas Health Science Center at Houston LC-MS
ST003917 AN006432 Gut Microbial Bile and Amino Acid Metabolism Associate with Peanut Oral Immunotherapy Failure Feces Human Allergy University of California, San Francisco LC-MS
ST003213 AN005269 The central role of creatine and polyamines in fetal growth restriction Placenta Human Placenta disease University of Udine LC-MS
ST002787 AN004535 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
ST002316 AN003783 Differential requirements for mitochondrial electron transport chain components in the adult murine liver - Untargeted Metabolomics (qTOF) Liver Mouse Metabolic syndrome University of Texas Southwestern Medical Center at Dallas LC-MS
ST002090 AN003414 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 2) Feces Mouse Irritable bowel syndrome Mayo Clinic LC-MS
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001866 AN003026 Systemic metabolite changes due to PHD inhibition Blood Mouse Northwestern University LC-MS
ST001865 AN003023 Systemic metabolite changes due to Hypoxia Blood Mouse Northwestern University LC-MS
ST001775 AN002882 Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi Blood Mouse Malaria Stanford University LC-MS
ST001688 AN002756 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism (part-II) Bacterial cells Bacteria Stanford University LC-MS
ST001683 AN002747 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. Blood Mouse Stanford University LC-MS
ST001683 AN002747 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. Cecum Mouse Stanford University LC-MS
ST001683 AN002747 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. Feces Mouse Stanford University LC-MS
ST001683 AN002747 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism. Urine Mouse Stanford University LC-MS
ST001671 AN002727 A gut microbe-focused metabolomics pipeline enables mechanistic interrogation of microbiome metabolism Bacterial cells Bacteria Stanford University LC-MS
ST001253 AN002081 Phenotyping Mouse blood metabolites in day and night in type 2 diabetes Blood Mouse Diabetes Indiana University School of Medicine LC-MS
ST001153 AN001903 Erythrocyte adenosine A2B receptor-mediated AMPK activation: Counteracting CKD by promoting oxygen delivery Blood Mouse Kidney disease University of Texas Health Science Center at Houston GC-MS
ST001144 AN001887 Microbial depletion and ozone exposure - serum (part II) Blood Mouse Asthma Harvard School of Public Health GC-MS/LC-MS
ST000930 AN001524 Define alterations in the gut metabolome of mice infected with C. difficile Cecum Mouse North Carolina State University LC-MS
  logo